• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1700013 重组抗肿瘤坏死因子α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2017-04-24 上海谐生医药科技有限公司 Shanghai Xiesheng Medical Technology Co Ltd Certificate Issued 2018-03-20 view
CXSL1900007 重组抗肿瘤坏死因子α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2019-01-29 百奥泰生物科技(广州)有限公司 Bio-Thera Solutions Ltd In Review 2019-01-28 view
CXSL1800048 重组抗肿瘤坏死因子-α(TNF-α)全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2018-04-28 山东丹红制药有限公司 Shandong Danhong Pharmaceutical Co Ltd Certificate Issued 2018-10-08 view
CXSL1300062 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2013-11-04 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2016-01-14 view
CXSL1300035 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2013-07-22 嘉和生物药业有限公司 Genor Biopharma Co Ltd Certificate Issued 2016-03-28 view
CXSL1500023 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2015-05-08 北京东方百泰生物科技有限公司 Beijing Dongfang Biotech Co Ltd Certificate Issued 2017-02-13 view
CXSL1700098 重组抗TNFα全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2017-11-01 安徽未名达木生物医药有限公司 Anhui Weiming Damu Biomedical Co Ltd Certificate Issued 2018-09-03 view
CXSL1400118 重组抗TNFα全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2015-03-24 上海迈泰亚博生物技术有限公司 Shanghai MabLab Biotechnology Co Ltd Certificate Issued 2016-09-03 view
CXSL1500038 重组抗TNFα全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2015-07-29 泰州迈博太科药业有限公司 Taizhou Maibotaike Pharmaceutical Co Ltd Certificate Issued 2016-06-27 view
CXSL1600095 重组抗TNFα全人单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2016-12-12 上海复宏汉霖生物技术有限公司 Shanghai Henlius Biotech Co Ltd Certificate Issued 2017-04-20 view
CXSL1300056 重组抗TNFα全人单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2013-12-23 上海复宏汉霖生物技术有限公司 Shanghai Henlius Biotech Co Ltd Certificate Issued 2016-01-14 view
CXSL1300088 重组抗TNFα全人单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2013-12-11 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd Certificate Issued 2016-06-27 view
CXSL1300087 重组抗TNFα全人单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2013-12-02 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd Certificate Issued 2016-06-27 view
CXSL1900004 重组抗TNF-α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2019-01-21 广东东阳光生物制剂有限公司 Guangdong HEC Bio&Pharm Co Ltd In Review 2019-01-18 view
CXSL1800067 重组全人源抗肿瘤坏死因子α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2018-06-14 神州细胞工程有限公司 SinoCelltech Ltd Certificate Issued 2018-10-15 view
CXSL1500089 重组全人源抗肿瘤坏死因子α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2015-11-19 神州细胞工程有限公司 SinoCelltech Ltd Certificate Issued 2017-05-22 view
CXSL1500080 重组全人源抗肿瘤坏死因子-α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2015-10-19 上海华奥泰生物药业有限公司 Shanghai Huaota Biopharmaceutical Co Ltd Certificate Issued 2016-12-30 view
CXSL1700057 重组全人源抗肿瘤坏死因子-α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2017-07-20 上海华奥泰生物药业有限公司 Shanghai Huaota Biopharmaceutical Co Ltd Certificate Issued 2018-06-28 view
CXSL1800014 重组全人源抗人TNF-α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2018-02-13 武汉生物制品研究所有限责任公司 Wuhan Institute of Biological Products Co Ltd In Review 2018-02-11 view
CXSL1700017 重组全人源抗TNF-α单抗注射液 adalimumab Injection Biological Products(2) New Drug Application 2017-09-14 北京双鹭药业股份有限公司 Beijing SL Pharmaceutical Co Ltd Certificate Issued 2018-09-03 view